Investment Securities (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 28, 2015
Accounting Policies [Abstract]
Common shares reclassified	66,667
Stock issued as license fee, shares		8,000,000
Stock issued as license fee, value		$ 100,000
Common shares of Entest Biomedical, Inc	8,066,667
Other than temporary impairment recognized	$ 41,333,361